HomeCompareRCGE vs MRK

RCGE vs MRK: Dividend Comparison 2026

RCGE yields 1.84% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $34.4K in total portfolio value
10 years
RCGE
RCGE
● Live price
1.84%
Share price
$27.81
Annual div
$0.51
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.4K
Annual income
$207.33
Full RCGE calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RCGE vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCGEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCGE + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCGE pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCGE
Annual income on $10K today (after 15% tax)
$156.44/yr
After 10yr DRIP, annual income (after tax)
$176.23/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,152.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCGE + MRK for your $10,000?

RCGE: 50%MRK: 50%
100% MRK50/50100% RCGE
Portfolio after 10yr
$39.6K
Annual income
$5,002.73/yr
Blended yield
12.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RCGE
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCGE buys
0
MRK buys
0
No recent congressional trades found for RCGE or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCGEMRK
Forward yield1.84%2.76%
Annual dividend / share$0.51$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$22.4K$56.8K
Annual income after 10y$207.33$9,798.13
Total dividends collected$2.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RCGE vs MRK ($10,000, DRIP)

YearRCGE PortfolioRCGE Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,884$184.05$11,206$366.19$322.00MRK
2$11,833$187.21$12,650$502.35$817.00MRK
3$12,852$190.22$14,407$694.19$1.6KMRK
4$13,944$193.08$16,585$967.82$2.6KMRK
5$15,116$195.79$19,342$1,363.89$4.2KMRK
6$16,373$198.36$22,913$1,947.19$6.5KMRK
7$17,720$200.79$27,662$2,823.89$9.9KMRK
8$19,163$203.10$34,159$4,173.35$15.0KMRK
9$20,710$205.27$43,337$6,308.80$22.6KMRK
10$22,367$207.33$56,776$9,798.13$34.4KMRK

RCGE vs MRK: Complete Analysis 2026

RCGEStock

RCGE is actively managed to provide exposure to a portfolio of companies committed to managing their organizations with a gender-balance approach. The eligible universe starts from the largest 3,000 stocks by market cap in developed markets, and the largest 1,000 stocks by market-cap in emerging markets. The fund filters stocks by looking at a companys gender equality score, which is based on gender balance, gender pay gap, and policies relating to parental leave and sexual harassment. Companies in which a score cannot be determined are excluded. An additional ethics screen is used to further narrow down the eligible universe. Lastly, the fund will look at a companys financial performance, mainly debt-to-equity ratio, debt-to EBITDA, and financial statement strength. The top 150 to 200 companies with the highest gender score that meet the financial criteria are selected. The fund imposes individual, countries, and sector caps. Rebalancing is done quarterly.

Full RCGE Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RCGE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCGE vs SCHDRCGE vs JEPIRCGE vs ORCGE vs KORCGE vs MAINRCGE vs JNJRCGE vs ABBVRCGE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.